Cost avoidance and outcome improvement by implementing a test utilization strategy for molecular microbiology tests

Jessica Ricaldi, Lori Racsa, Tobias Pusch, Rita M. Gander, Paul Southern, Dominick Cavuoti, Linda Byrd, Adnan Alatoom

Research output: Contribution to journalArticle

Abstract

Test utilization is an essential strategy in the clinical laboratory, especially with increasing numbers of tests and health care costs. We designed a triage system for molecular microbiology tests ordered from 2007 through 2010 to assess their appropriateness before they were sent out to a reference laboratory for testing. The number of tests ordered and approved and the number with positive results were calculated during the study period. Cost avoidance was subsequently calculated. A total of 13,839 tests were ordered, averaging 3,335 tests/year. The overall approval rate was 76%, ranging from 72% in 2007 to 81% in 2010. With the exception of cytomegalovirus (CMV) and BK virus PCR, the numbers of all tests decreased in 2010 compared to 2007. The total savings over 4 years was $374,791, with an average cost avoidance of $93,698/year. Pathologists and microbiologists should design a utilization system for laboratory testing to avoid unnecessary cost and improve patient care.

Original languageEnglish (US)
Pages (from-to)185-193
Number of pages9
JournalClinical Microbiology Newsletter
Volume36
Issue number23
DOIs
StatePublished - 2014

Fingerprint

Microbiology
Costs and Cost Analysis
BK Virus
Triage
Cytomegalovirus
Health Care Costs
Patient Care
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Cost avoidance and outcome improvement by implementing a test utilization strategy for molecular microbiology tests. / Ricaldi, Jessica; Racsa, Lori; Pusch, Tobias; Gander, Rita M.; Southern, Paul; Cavuoti, Dominick; Byrd, Linda; Alatoom, Adnan.

In: Clinical Microbiology Newsletter, Vol. 36, No. 23, 2014, p. 185-193.

Research output: Contribution to journalArticle

@article{00789f831f20413c9a196442712e1ae3,
title = "Cost avoidance and outcome improvement by implementing a test utilization strategy for molecular microbiology tests",
abstract = "Test utilization is an essential strategy in the clinical laboratory, especially with increasing numbers of tests and health care costs. We designed a triage system for molecular microbiology tests ordered from 2007 through 2010 to assess their appropriateness before they were sent out to a reference laboratory for testing. The number of tests ordered and approved and the number with positive results were calculated during the study period. Cost avoidance was subsequently calculated. A total of 13,839 tests were ordered, averaging 3,335 tests/year. The overall approval rate was 76{\%}, ranging from 72{\%} in 2007 to 81{\%} in 2010. With the exception of cytomegalovirus (CMV) and BK virus PCR, the numbers of all tests decreased in 2010 compared to 2007. The total savings over 4 years was $374,791, with an average cost avoidance of $93,698/year. Pathologists and microbiologists should design a utilization system for laboratory testing to avoid unnecessary cost and improve patient care.",
author = "Jessica Ricaldi and Lori Racsa and Tobias Pusch and Gander, {Rita M.} and Paul Southern and Dominick Cavuoti and Linda Byrd and Adnan Alatoom",
year = "2014",
doi = "10.1016/j.clinmicnews.2014.11.004",
language = "English (US)",
volume = "36",
pages = "185--193",
journal = "Clinical Microbiology Newsletter",
issn = "0196-4399",
publisher = "Elsevier Inc.",
number = "23",

}

TY - JOUR

T1 - Cost avoidance and outcome improvement by implementing a test utilization strategy for molecular microbiology tests

AU - Ricaldi, Jessica

AU - Racsa, Lori

AU - Pusch, Tobias

AU - Gander, Rita M.

AU - Southern, Paul

AU - Cavuoti, Dominick

AU - Byrd, Linda

AU - Alatoom, Adnan

PY - 2014

Y1 - 2014

N2 - Test utilization is an essential strategy in the clinical laboratory, especially with increasing numbers of tests and health care costs. We designed a triage system for molecular microbiology tests ordered from 2007 through 2010 to assess their appropriateness before they were sent out to a reference laboratory for testing. The number of tests ordered and approved and the number with positive results were calculated during the study period. Cost avoidance was subsequently calculated. A total of 13,839 tests were ordered, averaging 3,335 tests/year. The overall approval rate was 76%, ranging from 72% in 2007 to 81% in 2010. With the exception of cytomegalovirus (CMV) and BK virus PCR, the numbers of all tests decreased in 2010 compared to 2007. The total savings over 4 years was $374,791, with an average cost avoidance of $93,698/year. Pathologists and microbiologists should design a utilization system for laboratory testing to avoid unnecessary cost and improve patient care.

AB - Test utilization is an essential strategy in the clinical laboratory, especially with increasing numbers of tests and health care costs. We designed a triage system for molecular microbiology tests ordered from 2007 through 2010 to assess their appropriateness before they were sent out to a reference laboratory for testing. The number of tests ordered and approved and the number with positive results were calculated during the study period. Cost avoidance was subsequently calculated. A total of 13,839 tests were ordered, averaging 3,335 tests/year. The overall approval rate was 76%, ranging from 72% in 2007 to 81% in 2010. With the exception of cytomegalovirus (CMV) and BK virus PCR, the numbers of all tests decreased in 2010 compared to 2007. The total savings over 4 years was $374,791, with an average cost avoidance of $93,698/year. Pathologists and microbiologists should design a utilization system for laboratory testing to avoid unnecessary cost and improve patient care.

UR - http://www.scopus.com/inward/record.url?scp=84927511707&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927511707&partnerID=8YFLogxK

U2 - 10.1016/j.clinmicnews.2014.11.004

DO - 10.1016/j.clinmicnews.2014.11.004

M3 - Article

AN - SCOPUS:84927511707

VL - 36

SP - 185

EP - 193

JO - Clinical Microbiology Newsletter

JF - Clinical Microbiology Newsletter

SN - 0196-4399

IS - 23

ER -